Spotlight on dinutuximab in the treatment of high-risk neuroblastoma: development and place in therapy

Michelle E Keyel,1,2 C Patrick Reynolds1–4 1Cancer Center, 2Department of Pediatrics, 3Department of Internal Medicine, 4Department of Cell Biology & Biochemistry, School of Medicine, Texas Tech University Health Sciences Center, Lubbock, TX, USA Abstract: Neuroblastoma (N...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Keyel ME, Reynolds CP
Format: article
Langue:EN
Publié: Dove Medical Press 2018
Sujets:
GD2
Accès en ligne:https://doaj.org/article/54f44a9d7f4444ea894f7bcee0cad1d9
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!